Publications

You can use the filters to show only results that match your interests

Filter publications
175 publications by Advisory Council on the Misuse of Drugs ×
Get updates to this list email feed

Copy and paste this URL in to your feed reader

  1. ACMD members' register of interests

    • ACMD
    • Corporate report
  2. Legitimate use of controlled drugs: research and healthcare

    • ACMD
    • Correspondence
  3. ACMD letter to the Home Secretary: invitation to the drug strategy board

    • ACMD
    • Correspondence
  4. Commissioning impact on drug treatment

    • ACMD
    • Corporate report
  5. Home Office Science non-departmental public bodies (NDPBs): triennial review

    • Home Office, ACMD, NDNAD, ASC and Biometrics and Forensics Ethics Group
    • Corporate report
  6. Drug strategy 2016: development review

    • ACMD
    • Corporate report
  7. Psychoactive Substances Bill: evaluation review

    • ACMD
    • Corporate report
  8. Methiopropamine: a review of the evidence of use and harm

    • ACMD
    • Corporate report
  9. Methylphenidate-based novel psychoactive substances: temporary class drug order recommendations

    • ACMD
    • Policy paper
  10. Further advice on U-47,700, etizolam and other designer benzodiazepines

    • Home Office and ACMD
    • Correspondence
  11. Prescribing of controlled drugs by therapeutic radiographers: further advice

    • ACMD
    • Correspondence
  12. Advice on U-47,700, etizolam and other designer benzodiazepines

    • ACMD
    • Correspondence
  13. Letter from Sarah Newton: U-47,700 and designer benzodiazepines

    • ACMD
    • Correspondence
  14. Misuse of Drugs Regulations 2001: impact on research

    • ACMD
    • Correspondence
  15. Plant cannabinoids: ACMD report

    • ACMD
    • Policy paper
  16. Diversion & illicit supply of medicines

    • ACMD
    • Policy paper
  17. Reducing opioid-related deaths in the UK

    • ACMD
    • Independent report
  18. 'Third generation' synthetic cannabinoids

    • ACMD
    • Correspondence
  19. Temporary class drug order on methiopropamine

    • ACMD
    • Correspondence
  20. Problems for Ageing Drug Users Working Group: public meeting invitation

    • ACMD
    • Promotional material
  21. Independent prescribing of controlled drugs by therapeutic radiographers

    • ACMD
    • Correspondence
  22. ACMD work programme for 2016

    • ACMD
    • Correspondence
  23. ACMD review of alkyl nitrites (poppers)

    • ACMD
    • Correspondence
  24. Advice on the anticonvulsant drugs Pregabalin and Gabapentin

    • ACMD
    • Correspondence
  25. Advice on the steroid Dienedione

    • ACMD
    • Correspondence
  26. ACMD’s temporary class drug order report on Methiopropamine

    • ACMD
    • Correspondence
  27. ACMD public meeting: 24 November 2015

    • ACMD
    • Form
  28. ACMD’s final advice on definitions for the Psychoactive Substances Bill

    • ACMD
    • Correspondence
  29. How can opioid substitution therapy be optimised to maximise recovery outcomes for service users?

    • ACMD
    • Policy paper
  30. Ministerial response to ACMD report on cocaine misuse

    • DHSC, Home Office and ACMD
    • Correspondence
  31. Ministerial response to ACMD report on nitrous oxide misuse

    • DHSC, Home Office and ACMD
    • Correspondence
  32. ACMD interim advice: diversion and illicit supply of medicines

    • ACMD
    • Correspondence
  33. ACMD report on definitions for the Psychoactive Substances Bill

    • ACMD
    • Correspondence
  34. ACMD advice about Northern Ireland’s continued maintenance of the Addicts Index

    • ACMD
    • Correspondence
  35. ACMD letter to the Home Secretary: Psychoactive Substances Bill, 13 July 2015

    • ACMD
    • Correspondence
  36. ACMD letter to the Home Secretary: Psychoactive Substances Bill

    • ACMD
    • Correspondence
  37. Letter to Mike Penning on methylphenidate-based novel psychoactive substances

    • ACMD
    • Correspondence
  38. ACMD open meeting registration form: 2 July 2015

    • ACMD
    • Form
  39. Proposals to review and amend specific provisions under the Misuse of Drugs Regulations 2001

    • ACMD
    • Correspondence
  40. Electronic prescribing service for schedules 2 and 3 controlled drugs

    • ACMD
    • Correspondence